Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5-fluorouracil sensitivity in an East African population

Clinical studies have identified specific genetic variants in dihydropyrimidine dehydrogenase (DPD, DPYD gene) as predictors of severe adverse toxicity to the commonly used chemotherapeutic 5-fluorouracil; however, these studies have focused on European and European-American populations. Our lab rec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Pharmacol Ther
Main Authors: Elraiyah, Tarig, Jerde, Calvin R., Shrestha, Shikshya, Wu, Rentian, Nie, Qian, Giama, Nasra H., Sarangi, Vivekananda, Roberts, Lewis R., Offer, Steven M., Diasio, Robert B.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5309195/
https://ncbi.nlm.nih.gov/pubmed/27727460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.531
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares